The federal government is taking one of its biggest steps yet toward recognizing medical marijuana businesses under federal law. In recent weeks, the Drug Enforcement Administration (DEA) launched new registration forms and an online application portal for state-licensed medical marijuana dispensaries and related cannabis businesses. The move follows a major policy shift by the U.S. Department of Justice and the DEA to begin reclassifying certain medical cannabis products from Schedule I to Schedule III under the Controlled Substances Act. (Reuters)
For years, many states allowed medical cannabis programs — including Louisiana, Texas, Mississippi, and Arkansas — but federal law still classified marijuana as a Schedule I substance alongside drugs considered to have no accepted medical use. That conflict created problems involving taxes, banking, interstate commerce, and federal oversight. The new DEA registration process signals a major change in how the federal government plans to regulate medical cannabis businesses going forward. (Reuters)
The DEA has opened a new “Medical Marijuana Dispensary Registration Portal” that allows state-licensed medical marijuana businesses to apply for federal registration. (Reuters)
Under the new system, businesses involved in medical marijuana may now need to register directly with the DEA if they want protection under the federal rescheduling order. This includes dispensaries, distributors, and some manufacturers operating legally under state medical marijuana programs. (Cannabis Business Times)
According to the DEA and legal analyses published after the announcement, the registration application includes detailed sections covering:
Applicants are also required to pay an annual registration fee of approximately $794. (Reuters)
Last month, DEA launched a registration form for medical marijuana dispensaries only, raising questions about how operators elsewhere along the cannabis supply chain could become federally compliant during a 60-day registration window for expedited processing that is scheduled to close on June 26.
But now, the agency says that “in the coming weeks, an updated ‘Medical Marijuana Manufacturer’, ‘Medical Marijuana Bulk Manufacturer (grower/cultivator)’, ‘Medical Marijuana Analytical Lab’, and ‘Medical Marijuana Distributor’ application will be available specifically for handling Schedule III medical marijuana and posted on DEA Diversion’s Registration page.”
The new DEA forms are important because they could give federally recognized status to thousands of state-licensed medical marijuana businesses for the first time. Businesses that successfully register may receive several significant benefits.
One of the largest advantages involves taxes. Under current federal tax law, cannabis businesses have been heavily burdened by IRS Section 280E, which prevents many marijuana companies from deducting ordinary business expenses. The new Schedule III framework could remove or reduce those penalties for qualifying medical marijuana businesses. (Reuters) The U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following the rescheduling announcement.
Federal registration may also improve:
Some legal experts believe this could eventually help normalize the medical cannabis industry nationwide. (Sheppard Mullin)
The DEA established a limited registration window after launching the new portal. Businesses that apply within roughly 60 days of the federal notice may continue operating under their state licenses while the DEA reviews their applications. (Reuters)
Federal officials stated that early applications are expected to receive responses within six months. Companies that fail to register during the designated period could face additional federal scrutiny later. (Fennemore)
Several large cannabis companies have already announced that they submitted applications through the new DEA portal, including multistate operators such as Green Thumb Industries and Glass House Brands. (Cannabis Business Times)
For medical marijuana patients, the changes may eventually lead to a more stable and standardized industry. If more dispensaries become federally recognized, patients could see:
However, marijuana is still not fully legal at the federal level. Recreational cannabis businesses remain largely outside this new protection system for now, and many legal questions remain unresolved. (Reuters). In addition, CBD shops are not impacted by rescheduling. As for medical marijuana products, only those approved by the FDA will be included in the rescheduling.
The DEA’s rollout of new registration forms represents one of the most significant federal cannabis policy shifts in decades. While it stops short of nationwide legalization, it creates a pathway for state medical marijuana businesses to become federally regulated participants in the healthcare and pharmaceutical system. (Reuters)
Additional hearings regarding broader marijuana rescheduling are expected later in 2026, and many industry experts believe even larger reforms may still be ahead. (Department of Justice)
